Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Instruments to Enhance Middle East Diagnostic Services

By LabMedica International staff writers
Posted on 02 Feb 2015
A major international biomedical company has solidified its position in the Middle East diagnostics market with an impressive display of its latest automated instruments.

The Swiss diagnostics giant Roche (Basel, Switzerland) through its subsidiary Roche Diagnostics Middle East introduced several diagnostic systems at the 2015 Arab Health Exhibition & Congress in Dubai. More...
These systems had not been available previously in the region.

In particular, the display featured the cobas 8100 automated workflow system, the cobas t 411 coagulation analyzer, and the VENTANA HE 600 histopathology system.

The cobas 8100 system is made up of three stations: output, input, and aliquot stations. Each station can be configured according to the number of samples laboratories need to manage and the kind of workflow they want to run. The input station is the single point of entry which performs the first pre-analytical steps, identifies tube types and allows for automated centrifugation and decapping. The aliquot station enables secondary samples to be created without exposing healthcare professionals to open samples handling. It prepares the secondary samples for automated sorting, archiving, or analysis. The output station allows for mid-term storage of samples that could require additional processing, performs automated sorting and ruled-base recapping, all minimizing manual sample handling. The smart routing of samples is guided by a novel three-dimensional transport system that avoids traffic jams, in particular at high workload. This enables parallel handling of emergency (STAT) samples and routine testing.

The new cobas t 411coagulation analyzer was designed to allow maximum flexibility for laboratories with low-to-medium throughput and a unique set of enhanced safety features to ensure robust and high quality patient results. It features innovative sample and reagent management concepts such as automated multi-vendor cap-piercing, maximized reagent utilization, and integrated barcode scanning for samples and reagents and offers increased operator convenience and productivity.

The VENTANA HE 600 histopathology system is the next technological step following Roche's Symphony—the first fully automated H&E instrument. With the VENTANA HE 600 system laboratories can rely on fully automated, consistent high quality hematoxylin and eosin staining with no patient cross contamination in a simpler and more cost-effective and reliable way.

In parallel with the launch of diagnostic instruments, Roche introduced the "RDME Academy" at the Arab Health Exhibition & Congress. The RDME Academy is an online platform that makes real-time laboratory and learning tools accessible at the click of a mouse, through the RDME Academy website. The RDME Academy website affords users a comprehensive one-stop learning platform that gives them access to the entire training catalogue (including coursework, video, and presentation slides).

“In launching these new products at Arab Health, we have reaffirmed our dedication to the region and reinforced our commitment to providing first class diagnostics solutions - moving forward, our presence in the Middle East should allow us to continue to develop further breakthroughs and innovations,” said Moritz Hartmann, general manager of Roche Diagnostics Middle East. “These new diagnostic technologies were designed to help healthcare professionals deliver smooth, efficient in vitro diagnostics services, whilst also offering regional patient’s added peace of mind, as they can rest assured they are receiving industry-leading dedicated, safe, and efficient solutions.”

Related Links:

Roche 



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.